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nteraction of macrophages with apoptotic cells involves
multiple steps including recognition, tethering, phago-
cytosis, and anti-inﬂammatory macrophage responses.
Defective apoptotic cell clearance is associated with
pathogenesis of autoimmune disease. CD14 is a surface
receptor that functions in vitro in the removal of apoptotic
cells by human and murine macrophages, but its mecha-
nism of action has not been deﬁned. Here, we dem-
onstrate that CD14 functions as a macrophage tether-
ing receptor for apoptotic cells. Signiﬁcantly, CD14
 
 
 
/
 
 
 
macrophages in vivo are defective in clearing apoptotic
I
 
cells in multiple tissues, suggesting a broad role for CD14
in the clearance process. However, the resultant persis-
tence of apoptotic cells does not lead to inﬂammation or
increased autoantibody production, most likely because,
as we show, CD14
 
 
 
/
 
 
 
 macrophages retain the ability
to generate anti-inﬂammatory signals in response to
apoptotic cells. We conclude that CD14 plays a broad
tethering role in apoptotic cell clearance in vivo and that
apoptotic cells can persist in the absence of proinﬂammatory
consequences.
 
Introduction
 
Apoptosis culminates in the engulfment of apoptotic cells and
bodies where the phagocyte provides a safe haven for apoptotic
cell degradation, preventing environmental damage that is typi-
cal of necrotic cell death (for reviews see Henson et al., 2001;
Savill et al., 2002; Grimsley and Ravichandran, 2003; Gregory
and Devitt, 2004). In addition, the phagocytosis of apoptotic
cells normally results either in neutral responses from phago-
cytes or active suppression of inflammation through production
of anti-inflammatory mediators such as TGF-
 
 
 
1, PGE
 
2
 
, and
PAF (Voll et al., 1997; Fadok et al., 1998a, 2001; Kurosaka et
al., 2003) and triggering of tolerogenic responses in the adap-
tive immune system (for reviews see Savill et al., 2002; Albert,
2004). However, under certain circumstances, apoptotic cell
engulfment may be immunostimulatory, and the persistence of
apoptotic cells is associated in specific mouse strains with the
pathogenesis of autoimmune disease (Botto et al., 1998; Scott
et al., 2001; Cohen et al., 2002; Szondy et al., 2003; Hanayama
et al., 2004).
The removal of apoptotic cells by macrophages involves
a complex array of macrophage receptors, ill-defined apoptotic
cell–associated molecules, and soluble factors that link apoptotic
cells and macrophage surfaces (for reviews see Savill et al.,
2002; Gregory and Devitt, 2004). An attractive model has been
proposed where the molecules of apoptotic cell clearance
function in one or both of two major components of the clear-
ance process, (1) tethering and (2) “tickling” (Hoffmann et al.,
2001), the former events signifying binding of apoptotic cells
to phagocytes leading to the latter events that mediate signal
transduction to effect phagocytosis and anti-inflammatory
responses. Taken from the perspective of the macrophage,
available evidence now points to multiple phases in the process
of apoptotic cell clearance, including (a) discriminatory recog-
nition of apoptotic cells, (b) tethering of phagocyte receptors to
apoptotic cell–associated ligands, (c) phagocytic signaling, and
(d) anti-inflammatory signaling (Hoffmann et al., 2001; Savill
et al., 2002; Brown et al., 2002; Grimsley and Ravichandran,
2003; Gregory and Devitt, 2004).
CD14 is a pattern recognition receptor (PRR) that is
renowned for its ability to generate proinflammatory responses
following interaction with bacterial endotoxin, LPS (Goyert et
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al., 1988; Wright et al., 1990; Ulevitch and Tobias, 1995). In
vitro studies have shown that CD14 also plays a significant role
in the clearance of apoptotic cells by both human and murine
macrophages (Flora and Gregory, 1994; Devitt et al., 1998; Fa-
dok et al., 1998b; Schlegel et al., 1999). However, CD14-
dependent engulfment of apoptotic cells is not accompanied by
proinflammatory macrophage responses (Devitt et al., 1998).
Here, we investigate the mechanism of action of CD14 in apop-
totic cell clearance by macrophages. In both human and mouse
macrophage models, we demonstrate activity of CD14 as a
tethering receptor for apoptotic cells. We show in binding stud-
ies that soluble CD14 receptors can discriminate between via-
ble and apoptotic cells. Quantitative histological studies in-
dicate that CD14
 
 
 
/
 
 
 
 mice have defective clearance capacity
leading to persistence of apoptotic cells in multiple tissues.
However, such persistent apoptotic cells do not engender in-
flammatory responses, and CD14
 
 
 
/
 
 
 
 animals fail to develop in-
creased titers of autoantibodies or autoimmune disease. Indeed,
macrophages from CD14
 
 
 
/
 
 
 
 mice retain the ability to mount
anti-inflammatory responses to apoptotic cells. These findings
identify CD14 as a macrophage receptor that recognizes and
tethers apoptotic cells in preparation for engulfment. The
mechanism of action of CD14 can be functionally uncoupled
from the anti-inflammatory signaling events that accompany
apoptosis. These results demonstrate a mechanism by which
apoptotic cells can persist in vivo in the absence of inflamma-
tory consequences.
 
Results
 
Macrophage CD14 functions in 
apoptotic cell recognition and tethering 
in vitro
 
We first demonstrated a role for CD14 in the clearance of ap-
optotic cells by human macrophages using the inhibitory mAb
61D3. The capacity of this CD14 mAb (but not the CD14 mAb
63D3) to inhibit interaction of apoptotic cells with macro-
phages is confirmed in Fig. 1 A. To determine whether macro-
phages from CD14-deficient mice were similarly inhibited in
their capacity to interact with apoptotic cells, peritoneal or
bone marrow–derived macrophages (BMDMs) from CD14
 
 
 
/
 
 
 
versus CD14
 
 
 
/
 
 
 
 mice were compared. As shown in Fig. 1 (B
and C), BMDMs from CD14
 
 
 
/
 
 
 
 mice were substantially less
efficient than their CD14
 
 
 
/
 
 
 
 counterparts in interacting with
apoptotic cells, including both binding and phagocytic phases
(Fig. 1 C). In contrast, phagocytosis of IgG-opsonized cells
was equivalent for both CD14
 
 
 
/
 
 
 
 and CD14
 
 
 
/
 
 
 
 BMDMs (Fig.
1 D). Macrophages isolated from the peritoneal cavities of
CD14
 
 
 
/
 
 
 
 mice were also less effective in interacting with apop-
totic cells than their CD14
 
 
 
/
 
 
 
 counterparts, although the differ-
ence was less marked than with BMDMs (Fig. 1 E). These re-
sults confirm and extend previous observations demonstrating
a role for macrophage CD14 as a receptor for apoptotic cells.
To investigate tethering events independently of phago-
cytosis, macrophage–apoptotic cell interactions were con-
ducted at 16–20
 
 
 
C, which permitted binding, but not phago-
cytic, events to occur (Fig. 2 and not depicted). Tethering
of apoptotic cells to human monocyte-derived macrophages
(HMDMs) was reduced significantly by mAb 61D3 but not
by mAb 63D3 (Fig. 2 A). Enhanced tethering of apoptotic
cells induced by transient expression of CD14 in COS trans-
fectants (Fig. 2 C) was returned to background levels by
61D3 (Fig. 2 B). BMDMs (Fig. 2 D) and peritoneal macro-
phages (Fig. 2 E) from CD14
 
 
 
/
 
 
 
 mice also bound apoptotic
Figure 1. CD14 dependence of interaction of apoptotic cells with human
and murine macrophages. (A) Interaction (binding and phagocytosis) of 7-d
HMDMs with apoptotic BL cells. Interaction between HMDMs and apop-
totic BL cells (AC) was assessed after 60-min coculture at 37 C in the pres-
ence or absence of CD14 mAbs 61D3 or 63D3. Background interaction
of apoptotic cells in the macrophage cultures without added BL cells is also
shown (Alone). Results represent the percentage of macrophages interact-
ing with apoptotic cells. Data shown are means   SEM (n   2). ANOVA:
**, P   0.01. (B) Interaction of 10-d BMDMs from CD14
 /  (gray bar)
and CD14
 /  (black bar) mice with apoptotic BL cells assessed after 30-
min coculture at 37 C. Data shown are means   SEM (n   3). ANOVA:
*, P   0.05. Similar results were observed when syngeneic apoptotic thy-
mocytes were tested in place of BL cells. (C) Photomicrographs showing
10-d BMDMs’ interaction with apoptotic BL cells, comprising binding
(arrowheads) and phagocytic (arrows) events. (D) Interaction of IgG-
opsonized BL cells with the same macrophages as in B. Data are means  
SEM (n   3). (E) Interaction of peritoneal macrophages from CD14
 / 
(gray bar) and CD14
 /  (black bar) mice with apoptotic BL cells assessed
after 30-min coculture at 37 C. Data shown are means   SEM (n   3).
ANOVA: *, P   0.05. 
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cells less effectively than their CD14
 
 
 
/
 
 
 
 counterparts. Finally,
to determine whether or not CD14 is involved directly in the
discrimination of viable and apoptotic cells, purified recombi-
nant forms of CD14 were assessed for cell-binding ability. As
shown in Fig. 2 F, recombinant CD14 bound apoptotic, but
not viable, cells. The latter result raises the possibility that
soluble CD14, which is present in high amounts in plasma
and secretions might also be involved in apoptotic cell clear-
ance. Together, these results demonstrate in both human and
murine systems that CD14 can function independently of pha-
gocytic events by tethering apoptotic cells to macrophages.
Because of its relative specificity for apoptotic over viable
cells, we conclude that CD14 also contributes to apoptotic
cell recognition by macrophages.
 
Increased incidence of apoptotic cells in 
tissues of CD14
 
 
 
/
 
 
 
 mice
 
If CD14’s role in the clearance process were redundant in vivo,
the frequency of apoptotic cells in histological sections should
be equivalent in tissues of CD14
 
 
 
/
 
 
 
 and CD14
 
 
 
/
 
 
 
 mice. We ini-
tially analyzed the normal thymus of young adult animals be-
cause apoptosis normally occurs at high rate in this tissue and
apoptotic thymocytes can be readily observed in situ (Surh and
Sprent, 1994). Macroscopically, no differences were noted be-
tween CD14
 
 
 
/
 
 
 
 and CD14
 
 
 
/
 
 
 
 thymi, and no overt microscopic
differences in cellularity or tissue architecture were observed.
However, quantitative analyses of apoptotic thymocytes identi-
fied by in situ end labeling (ISEL; Fig. 3 A) revealed increased
frequencies of apoptotic events in both the cortex and medulla
of the CD14
 
 
 
/
 
 
 
 thymus compared with its CD14
 
 
 
/
 
 
 
 counter-
part. Detailed morphological analyses of thymic cortex in tolu-
idine blue–stained, resin-embedded sections allowed apoptotic
 
Figure 2.
 
Macrophage tethering of apoptotic cells by CD14.
 
 (A) Binding
(in the absence of phagocytosis) of apoptotic BL cells (AC) by HMDMs
assessed after coculture at 16–20
 
 
 
C for 60 min in the presence or absence
of CD14 mAbs 61D3 or 63D3. Data shown are means 
 
 
 
 SEM (
 
n 
 
  
 
2).
ANOVA: *, P 
 
  
 
0.05. (B) Binding of apoptotic BL cells (AC) by either
mock-transfected or 
 
CD14
 
-transfected COS-1 cells after coculture at 16–
20
 
 
 
C for 60 min in the presence (gray bar) or absence (black bar) of
CD14 mAb 61D3. (inset) Expression of CD14 by COS-1 cells as assessed
by flow cytometry following immunofluorescence staining using mAb
63D3 and goat anti–mouse-FITC (shown in red) versus staining of mock
transfectants (shown in blue). ANOVA: ***, P
 
 
 
  
 
0.001. (C) Photomicro-
graphs showing binding (but not phagocytosis) of apoptotic BL cells by
COS cells. Binding is promoted by the expression of CD14 (arrow). (D)
Binding of 10-d BMDMs from CD14
 
 
 
/
 
 
 
 (gray bar) and CD14
 
 
 
/
 
 
 
 (black
bar) mice with apoptotic BL cells assessed after 30-min coculture at 16–
20
 
 
 
C. Data shown are means 
 
 
 
 SEM (
 
n 
 
  
 
3). ANOVA: ***, P
 
 
 
  
 
0.001.
(E) Binding of peritoneal macrophages from CD14
 
 
 
/
 
 
 
 (gray bar) and
CD14
 
 
 
/
 
 
 
 (black bar) mice with apoptotic BL cells assessed after 30-min
coculture at 16–20
 
 
 
C. Data shown are means 
 
 
 
 SEM (
 
n 
 
  
 
3). ANOVA:
***, P
 
 
 
 
 
 0.001. (F) Binding of soluble recombinant human CD14
(sCD14) to apoptotic cells. BL cells undergoing spontaneous apoptosis
were identified as “apoptotic” or “viable” according to light-scatter
properties and confirmed by morphological analyses (Dive et al., 1992).
Spontaneous apoptosis, a characteristic feature of group I BL cell lines
(Gregory et al., 1991) was confirmed by morphological analysis as
described previously (Devitt et al., 2003). Histograms of recombinant
forms of CD14, sCD14-Fc, and sCD14-HIS binding to cells in these zones
are shown. Control staining is shown in blue against staining with SCD14-
Fc and SCD14-HIS in red. 
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cells to be defined as either “free” or “macrophage-associated”
(Fig. 3 B). Quantitative analyses indicated that, although there
were increased numbers both of free and of macrophage-asso-
ciated apoptotic cells in the cortices of CD14
 
 
 
/
 
 
 
 compared with
CD14
 
 
 
/
 
 
 
 thymi, the ratio of free/macrophage-associated events
was substantially higher in the CD14
 
 
 
/
 
 
 
 animals (Fig. 3 B) de-
spite equivalent distribution of macrophages throughout the
thymus as assessed by F4/80 staining (Fig. 3 C). Similar results
showing the presence of free apoptotic cells in thymus of
CD14
 
 
 
/
 
 
 
 and CD14
 
 
 
/
 
 
 
 mice were obtained after annexin V
(AxV) and propidium iodide (PI) staining of dissociated thymi
(see Fig. 5 A). Earlier studies have reported marginally lower
levels of free apoptotic cells in the murine thymus than those
reported here (Surh and Sprent, 1994; McIlroy et al., 2000), al-
though it is important to note that different mouse strains and
methodologies were used.
To extend these observations of basal apoptosis to other
tissues, we compared the spleens of CD14
 
 
 
/
 
 
 
 and CD14
 
 
 
/
 
 
 
animals using identical approaches. As with the thymus, no
overt macroscopic differences between CD14
 
 /  and CD14
 / 
spleens were noted. However, the numbers of positive apop-
totic events by ISEL were substantially elevated in the red
and white pulp of the spleens of CD14
 /  animals (Fig. 3 D).
This finding was confirmed in detailed morphological analy-
sis of the red pulp where it was found that the majority of ap-
optotic cells were free, rather than macrophage-associated, in
the CD14
 /  animals (Fig. 3 E). Conversely, in the CD14
 / 
mice, the ratio of free/macrophage-associated apoptotic cells
was reversed with most apoptotic events being macrophage-
associated (Fig. 3 E). Splenic macrophage distribution was
similar throughout the CD14
 /  and CD14
 /  spleen (Fig. 3
F). Quantitative ISEL analyses of lung, liver, and large intes-
tine confirmed the trends observed in thymus and spleen, with
increased frequencies of apoptotic events in the CD14
 /  tis-
sues (Fig. 3 G) although the differences between the large in-
testines of CD14
 /  and CD14
 /  animals were not statisti-
cally significant. No signs of inflammatory cell infiltration
were observed in any of the tissues studied as illustrated in
sections of thymus shown in Fig. 3 H.
These data suggest either that apoptosis was increased
at multiple sites as a result of CD14 deficiency or that the ab-
sence of CD14 led to persistence of apoptotic cells as a result
of their inefficient clearance. Given the mode of action of
CD14 indicated by the in vitro studies, together with the rela-
tive preponderance of free, as opposed to macrophage-associ-
ated, apoptotic cells in the spleen and thymus of CD14
 / 
animals, these results strongly argue that the increased fre-
quencies of apoptotic events encountered in the tissues of
CD14
 /  mice results from reduced clearance rather than
from increased apoptosis.
Figure 3. Persistence of apoptotic cells in tissues of normal CD14
 / 
mice. (A) Morphometric analysis of the frequency of ISEL
  nuclei present in
the thymic cortex and medulla of CD14
 /  and CD14
 /  mice. (B) Quan-
titative analyses of thymic sections showing the numbers of free and mac-
rophage-associated apoptotic cells together with the ratios of free/macro-
phage-associated apoptotic cells for CD14
 /  and CD14
 /  cortices. (C)
Morphometric analyses of the distribution of macrophages (F4/80-reactive
material) in the cortex and medulla of CD14
 /  and CD14
 /  thymus. All
thymus data shown are means   SEM (n   3 animals in each case).
ANOVA: *, P   0.05; **, P   0.01. (D) Morphometric analysis of the
frequency of ISEL
  nuclei present in the splenic red and white pulp of
CD14
 /  and CD14
 /  mice. ANOVA: ***, P   0.001. (E) Quantitative
analysis of the numbers of free and apoptotic cells together with the ratios
of free/macrophage-associated apoptotic cells for CD14
 /  and CD14
 / 
splenic red pulp. (F) Morphometric analyses of the distribution of F4/80
 
macrophages in the cortex and medulla of CD14
 /  and CD14
 / 
spleen. All spleen data shown are means   SEM (n   3 animals in each
case). ANOVA: *, P   0.05; ***, P   0.001. (G) Persistence of apoptotic
cells in non-lymphoid tissues of CD14
 /  mice. Morphometric analyses of
the frequency of ISEL
  nuclei present in the lung, liver, and large intestine
(LI) of CD14
 /  and CD14
 /  mice. Data are means   SEM (n   3 ani-
mals in each case). ANOVA: *, P   0.1; **, P   0.01. (H) Photomicro-
graphs showing histological detail of CD14
 /  versus CD14
 /  thymus.
Note preponderance of free apoptotic cells in CD14
 /  thymus (arrows)
and absence of inflammatory cell infiltrate.CD14 MEDIATES TETHERING OF APOPTOTIC CELLS • DEVITT ET AL. 1165
Defective apoptotic cell clearance by 
CD14
 /  macrophages in vivo
To define more precisely if CD14
 /  mice display defects in
their ability to clear apoptotic cells in vivo, we determined
the extent to which apoptotic cells administered i.p. could be
cleared by resident macrophages. To this end, CD14
 /  or
CD14
 /  mice were injected i.p. with fluorescent, apoptotic
thymocytes and after 15 min coincubation in situ the propor-
tion of peritoneal macrophages interacting with apoptotic
cells was enumerated by flow cytometry following F4/80 im-
munofluorescence staining (Fig. 4). As shown, effective dis-
crimination of apoptotic thymocytes, F4/80
  macrophages,
and macrophages interacting with apoptotic thymocytes was
possible (Fig. 4 A). Microscopic analyses of sorted popula-
tions indicated that those events displaying dual fluorescence
(i.e., F4/80
 , apoptotic cell
 ) represented macrophages with
bound and/or engulfed apoptotic thymocytes (unpublished
data). Quantitative analysis of multiple experiments (Fig. 4
B) showed that peritoneal macrophages from CD14
 /  ani-
mals were markedly reduced in their ability to interact with
apoptotic cells to a level that was approximately half the ca-
pacity of CD14
 /  macrophages. These results provide fur-
ther evidence that apoptotic cells persist in CD14
 /  mice as
a result of defective clearance by macrophages.
In situ apoptotic cell clearance is 
inefficient in CD14
 /  thymi after 
triggering synchronous thymocyte 
apoptosis
The i.p. investigations outlined in the previous section sug-
gested that CD14
 /  macrophages were less able than their
CD14
 /  counterparts to clear a burden of apoptotic cells in
situ. We wished to determine whether or not macrophages else-
where were similarly deficient. Therefore, we used dexametha-
sone treatment to elicit massive, synchronous thymocyte apop-
tosis in situ in CD14
 /  and CD14
 /  mice and assessed the
persistence of these cells quantitatively by flow cytometry.
Thymi from dexamethasone-treated animals were markedly
smaller than those of mock (PBS)-treated animals. ISEL of thy-
mic sections demonstrated substantial apoptosis induced by
dexamethasone notably in the cortices of both CD14
 /  and
CD14
 /  thymi (unpublished data). In contrast, control, mock-
treated animals displayed much less ISEL product, with
CD14
 /  animals showing obviously greater numbers of apop-
totic events than their CD14
 /  counterparts confirming our
earlier results (illustrated in Fig. 3 A). Disruption of thymi and
flow cytometric assessment of apoptosis in the resulting cell
suspensions showed that higher levels of dying and dead thy-
mocytes could be isolated from CD14
 / , as compared with
Figure 4. Inefficient interaction of apoptotic thymocytes with resident
peritoneal macrophages in CD14
 /  mice. Fluorescent (green) autologous
apoptotic thymocytes in PBS were introduced into the peritoneal cavity of
CD14
 /  or CD14
 /  mice by i.p. injection. Control animals received i.p.
PBS alone. After 15 min, peritoneal cells were harvested, stained with F4/
80, and analyzed by flow cytometry. Similar numbers of resident F4/80
 
peritoneal macrophages were obtained from CD14
 /  and CD14
 /  ani-
mals. (A) Representative flow cytometric dot plots of apoptotic (green) cells
(AC) versus (red) F4/80
  events (macrophages). (B) Collated data from
CD14
 /  and CD14
 /  mice tested (means   SEM; n   3 animals in
each case). ANOVA: *, P   0.05.
Figure 5. Persistence of apoptotic cells in thymus of CD14 mice after dexa-
methasone treatment. (A) Flow cytometric analyses of thymocytes har-
vested from mock (C) or dexamethasone (DEX)-treated CD14
 /  or
CD14
 /  mice. Left, percentage of total AxV
  cells; right, percentage of
apoptotic (AxV
 PI
 ) or secondarily necrotic (AxV
 PI
 ) cells. ANOVA: **,
P   0.01; ***, P   0.001. (B) Induction of apoptosis by dexamethasone
treatment of thymocytes from CD14
 /  (open diamonds) or CD14
 / 
(closed squares) mice in vitro. Left, generation of apoptotic (AxV
 PI
 ) cells
with time; right, generation of necrotic (AxV
 PI
 ) cells with time. Data
shown are means   SEM (n   3 animals per group).JCB • VOLUME 167 • NUMBER 6 • 2004 1166
CD14
 / , mice. These levels were significantly increased by
dexamethasone treatment (Fig. 5 A). When the AxV-positive
cells were assessed for loss of membrane integrity (secondary
necrosis) using PI, significantly higher levels of PI
  cells
following dexamethasone treatment were observed both in
CD14
 /  and CD14
 /  populations (Fig. 5 A). Because these
AxV
  PI
  cells were apoptotic cells (as judged by their mor-
phology; unpublished data) that had lost membrane integrity,
these results suggested that the massive, synchronous apoptosis
induced by dexamethasone overloaded the phagocytic capacity
of the thymi of both CD14
 /  and CD14
 /  animals. These ob-
servations are consistent with the conclusion that thymocytes
that were not cleared rapidly were permitted to undergo post-
apoptotic changes akin to those occurring in vitro in the ab-
sence of phagocytes. However, the overload was more marked
in the samples from CD14
 /  thymi because significantly
higher levels of total AxV
  and of AxV
  PI
  cells were iso-
lated in comparison to CD14
 /  thymi (Fig. 5 A).
To address the possibility that thymocytes from CD14
 / 
animals were more sensitive to dexamethasone-induced apop-
tosis, we isolated thymocytes from wild-type and CD14
 /  ani-
mals, treated them with dexamethasone in vitro, and followed
the kinetics of apoptosis. No significant differences in the rates
of apoptosis (AxV
  PI
 ) or secondary necrosis (AxV
  PI
 ) were
demonstrable between CD14
 /  and CD14
 /  thymocytes, in-
dicating that CD14
 /  and CD14
 /  thymocytes were not dif-
ferentially sensitive to dexamethasone (Fig. 5 B). These results
provided further evidence that apoptotic cell clearance was de-
fective in CD14
 /  mice.
CD14 deficiency does not promote 
inflammation or autoantibody production, 
and CD14
 /  macrophages retain the 
capacity to generate anti-inflammatory 
responses to apoptotic cells
Persistence of apoptotic cells in vivo was expected to be asso-
ciated with inflammation and increased autoantibody produc-
tion. However, CD14
 /  mice showed no overt inflammatory
lesions (Fig. 3 H and not depicted) or increased serum concen-
tration of TNF-  (not depicted) despite the chronic presence of
apoptotic cells within tissues. We also monitored autoantibody
titers and autoimmune disease pathology in aged animals and
found titers of anti-nuclear antibodies (ANA) were comparable
in sera of CD14
 /  and CD14
 /  animals (Fig. 6 A). Extensive
histopathological analyses of tissues from these animals (un-
published data) indicated no end organ effects. Thus, in these
animals, persistence of apoptotic cells resulting from the ab-
sence of CD14 does not augment autoantibody production or
lead to increased susceptibility to autoimmune disease.
In light of these data, we wished to assess whether or not
CD14
 /  macrophages were sensitive to the induction of anti-
inflammatory pathways in response to interactions with apop-
totic cells as defined in previous studies (Voll et al., 1997; Fa-
dok et al., 1998a). As shown in Fig. 6 B, CD14
 /  macrophages
were found to be as effective as their CD14
 /  counterparts in
producing the anti-inflammatory cytokine TGF-  in response to
apoptotic cells. Furthermore, CD14
 /  macrophages elicit sig-
nificant TNF-  production in response to opsonized zymosan (a
CD14-independent proinflammatory stimulus) that is inhibited
following macrophage interaction with apoptotic cells (Fig. 6
C). These results indicate that the immuno-modulatory effects
of apoptotic cells on macrophages are functional in the absence
of CD14, providing a rationale for the observed absence of in-
flammatory consequences of CD14 deficiency in vivo.
Discussion
The present work was undertaken as a direct extension of our
previous work demonstrating that CD14 on human macro-
phages plays a key role in the clearance of apoptotic cells in
vitro (Devitt et al., 1998, 2003). Here, we show (a) that CD14
acts as a tethering receptor of apoptotic cells, (b) that, in ani-
mals deficient in CD14, apoptotic cells are cleared sub-opti-
mally, resulting in increased frequencies of apoptotic cells and
bodies at multiple sites in situ, and (c) that such persistent ap-
optotic cells are not proinflammatory.
Figure 6. Persistence of apoptotic cells in CD14
 /  mice
does not lead to increased autoantibody production or in-
flammation. (A) Autoantibody production is not increased in
CD14
 /  mice. Titers of ANA antibodies in sera from aged
CD14
 /  and CD14
 /  mice were assessed by indirect
immunofluorescence. See text for details. “ ” denotes negative
samples. (B) CD14
 /  macrophages produce TGF-  effec-
tively in response to apoptotic cells. TGF-  concentration in
the supernatants of peritoneal macrophages following 18-h
stimulation alone or with apoptotic thymocytes (AC). Data
shown are means   SEM, n   5. ANOVA: ***, P   0.001.
(C) Apoptotic cells can inhibit proinflammatory responses of
CD14-deficient macrophages. (left) TNF-  concentration in
the supernatants of 10-d BMDMs following 18-h stimulation
with both or either opsonized zymosan (Zy) and apoptotic
thymocytes (AC). Data shown are means   SEM, n   3.
ANOVA: ***, P   0.001.CD14 MEDIATES TETHERING OF APOPTOTIC CELLS • DEVITT ET AL. 1167
Our conclusion that the observed phenotype of CD14
 / 
mice is due to the persistence of apoptotic cells as a result of
impaired clearance, rather than to increased apoptosis, is based
on several observations. First, our quantitative histological
analyses suggested that, in tissues of CD14
 /  animals, fewer
apoptotic cells were associated with macrophages as compared
with those of wild-type animals. Second, we found that macro-
phages from CD14
 /  animals were less effective than their
normal counterparts in clearing apoptotic cells in standard in
vitro assays despite equivalent clearance of antibody-opsonized
cells regardless of CD14 expression, indicating that CD14
 / 
macrophages are not fundamentally flawed in their capacity to
phagocytose. CD14-deficient macrophages are similarly unim-
paired in their ability to phagocytose whole bacteria (Moore et
al., 2000). Third, when apoptotic cells were introduced into the
peritoneal cavity and permitted to interact with peritoneal mac-
rophages in a well-established short-term in vivo assay (Taylor
et al., 2000), CD14
 /  macrophages were found to be less ef-
fective than their CD14
 /  counterparts in binding and phago-
cytosing apoptotic cells. Finally, we used dexamethasone to
induce massive, synchronous thymocyte apoptosis in situ.
Again, we found that the phagocytosis of the apoptotic cells
so induced in the CD14
 /  animals was less effective than in
CD14
 /  animals, leading to persistence of greater numbers of
free apoptotic cells. Significantly, thymocytes from CD14
 / 
and CD14
 /  animals were similarly sensitive to apoptosis in-
duction by dexamethasone.
As well as playing a role in apoptotic cell clearance,
CD14 is functional in innate immune responses against micro-
bial products, particularly LPS (for reviews see Ulevitch and
Tobias, 1995; Kitchens, 2000). However, subtle infections re-
sulting from the absence of CD14 are unlikely to account for
the increased numbers of apoptotic cells observed in the tissues
of CD14
 /  mice. Although infectious agents can induce apop-
tosis in tissues, including the thymus (Ayala et al., 1996;
Hotchkiss et al., 2001), the animals used for these studies were
healthy and fertile and it should be noted that the normal
phagocytic capacity of mice is such that increased numbers of
free apoptotic cells are observed only when massive levels of
synchronous apoptosis are induced causing overload of the
clearance mechanisms (for review see Ogasawara et al., 1993)
or when the clearance mechanisms themselves are compro-
mised (Botto et al., 1998; Hamon et al., 2000; Scott et al.,
2001; Li et al., 2003; Hanayama et al., 2004). Here, we have
used a range of in vitro and in vivo assays of apoptotic cell
clearance that accord with each other and are consistent with
the conclusion that CD14
 /  animals are inefficient in clearing
apoptotic cells rather than being more susceptible to the induc-
tion of apoptosis.
CD14 is one of several macrophage receptors implicated,
mainly through in vitro studies, in the clearance of apoptotic
cells. The results presented here indicate that CD14 plays a
non-redundant or only partially redundant role in apoptotic cell
clearance in normal animals. We observed persistence of apop-
totic cells in all tissues studied—thymus, spleen, lung, liver,
and gut. This finding contrasts with animals that are function-
ally deficient in the Mer tyrosine kinase, which also display an
apoptotic cell clearance defect in vivo. In unchallenged ani-
mals, clearance of apoptotic cells in the thymus, the only tissue
thus far reported, was found to be normal in Mer-deficient
mice; treatment with dexamethasone was required to reveal the
clearance defect in situ (Scott et al., 2001). SR-A–deficient thy-
mic macrophages, which are defective in their capacity to en-
gulf apoptotic thymocytes in vitro, are uncompromised in SR-
A–deficient thymi in situ even when thymocyte apoptosis is
accelerated by irradiation (Platt et al., 2000). Clearly, therefore,
the functions of CD14, Mer, and SR-A in enabling or support-
ing apoptotic cell clearance in vivo are separable. Besides
CD14, the only other molecules whose absence has thus far
been reported to generate apoptotic cell clearance defects in
unchallenged adult tissue in situ are the bridging molecules
C1q and MFG-E8 (Botto et al., 1998; Hanayama et al., 2004).
C1q deficiency leads to the persistence of apoptotic cells spe-
cifically in glomeruli of genetically susceptible mice (Botto et
al., 1998). In MFG-E8–deficient mice, apoptotic cell engulf-
ment is impaired in the germinal centers of secondary lym-
phoid follicles (Hanayama et al., 2004). Apoptotic cells appear
not to persist at other sites in either C1q- or MFG-E8–deficient
mice. Significantly, consequences of the absence of CD14 are
manifest widely with all adult tissues examined thus far dis-
playing persistence of apoptotic cells in situ. We conclude that
CD14 has a broad role, being required for efficient apoptotic
cell clearance at multiple tissue sites.
Although the detailed molecular mechanisms underlying
CD14’s involvement in apoptotic cell clearance have yet to be
defined, they differ from those involving C1q, Mer, and MFG-
E8. C1q appears to bridge apoptotic cells to CD91/calreticulin
on phagocytes (Ogden et al., 2001), Mer probably associates
with apoptotic cell surface phosphatidylserine (PS) via the
bridging protein Gas6 (Ishimoto et al., 2000), and MFG-E8
bridges PS to phagocyte vitronectin receptor integrins (Ha-
nayama et al., 2002). Notably, tethering of apoptotic cells ap-
pears to be normal in both Mer- and MFG-E8–deficient ani-
mals (Scott et al., 2001; Hanayama et al., 2004). Previous work
has suggested that CD14 functions to tether apoptotic cells to
the phagocyte surface (Devitt et al., 1998; Hoffmann et al.,
2001). We now provide strong evidence in support of this no-
tion, demonstrating a role for CD14 in tethering apoptotic cells
to macrophages and showing that purified CD14 can bind ef-
fectively to apoptotic, but not viable, cells. Therefore, CD14’s
major, and perhaps sole, function in clearing apoptotic cells
may be in the initial recognition and binding phase of the
process. In this model, additional receptor–ligand interactions
(e.g., PS exposed on apoptotic cells binding via Gas6 to Mer
[Ishimoto et al., 2000] or via MFG-E8 to vitronectin receptors
[Hanayama et al., 2002]) would be required to induce phagocy-
tosis/anti-inflammatory responses in the phagocyte.
In the present scenario, even though CD14 deficiency
leads to persistence of apoptotic cells in many locations, such
persistence is not accompanied by inflammatory reactions at
these sites. This contrasts with the effects of massive apoptosis,
which can generate inflammatory effects (Uchimura et al.,
2000; Lorimore et al., 2001). Evidence has been provided that
defective apoptotic cell clearance, given appropriate geneticJCB • VOLUME 167 • NUMBER 6 • 2004 1168
background (C57BL/6,129 or mixed), is associated with in-
creased productivity of autoantibodies and increased incidence
of autoimmune disease (Botto et al., 1998; Scott et al., 2001;
Mitchell et al., 2002; Cohen et al., 2002; Szondy et al., 2003;
Hanayama et al., 2004). However, a causative link between de-
fective apoptotic cell clearance and autoimmune disease patho-
genesis is far from clear because of the strains of mice used
(Bygrave et al., 2004). Significantly, autoantibody production
is not enhanced in the CD14
 /  animals investigated here.
Balb/c animals, the background strain used here, are not inher-
ently resistant to autoimmune disease (Horai et al., 2000; Rud-
ner et al., 2003). Our results are consistent with the idea that
CD14 provides a non-redundant tethering mechanism that fa-
cilitates the interaction of apoptotic cells with macrophages.
Although this mechanism is absent in CD14
 /  mice, the sig-
naling mechanisms that prevent inflammatory and possibly au-
toimmune responses to persistent apoptotic cells appear to
remain intact. Therefore, the tethering activity of CD14 in
clearing apoptotic cells can be functionally uncoupled from the
mechanisms that prevent such cells generating inflammatory or
immunostimulatory responses. This supports the view that dif-
ferent receptor–ligand interactions are required for different
phases of the clearance process as we and others have previ-
ously proposed. The functional separation of anti-inflammatory
and engulfment signaling events has been described recently
(Cvetanovic and Ucker, 2004).
Because apoptotic cell phagocytosis appears to be re-
duced rather than blocked in CD14
 /  mice, it would appear
that additional clearance mechanisms are also operable. Such
mechanisms may include lower affinity tethering mechanisms
and mechanisms that relate specifically to apoptotic cells at
later stages than those normally detected by CD14. The relative
inefficiency of these mechanisms that causes apoptotic cell
persistence is indicative of a non-redundant or only partially re-
dundant role for CD14 in the clearance of apoptotic cells.
The binding of purified CD14, a prototypical PRR, to ap-
optotic but not viable cells indicates that activation of the apop-
tosis program leads to the display of cellular CD14-ligands. In
line with the conserved microbial PRR ligands (such as LPS)
being termed pathogen-associated molecular patterns (PAMPs),
such host PRR ligands have been collectively termed apoptotic
cell–associated molecular patterns (ACAMPs; Franc et al.,
1999; Gregory, 2000). A key difference between ligation of
PRRs by PAMPs versus ACAMPs is the response of the host
cell, with PAMPs generating proinflammatory and ACAMPs
anti-inflammatory responses. Of critical importance to under-
standing CD14’s role in apoptotic cell clearance is defining the
mechanistic differences underlying responses to PAMPs versus
ACAMPs. We have previously proposed several scenarios in-
cluding a “minimalist” view of CD14 acting solely as a tether-
ing receptor (Gregory, 2000; Gregory and Devitt, 2004). The
present results support this view but do not preclude CD14
playing additional roles in the clearance process, for example
cooperating with molecular partners to generate or facilitate in-
tracellular signals for engulfment. In this context, cooperation
with toll-like receptors, as in the generation of proinflamma-
tory responses to PAMPs, appears unlikely (Li et al., 2001;
Blander and Medzhitov, 2004; Cvetanovic and Ucker, 2004;
Shiratsuchi et al., 2004).
The results presented here first demonstrate that absence
of the mechanism(s) served by CD14 in the phagocytic clear-
ance of apoptotic cells reveals apoptosis in multiple tissues.
The lack of the CD14-dependent mechanism(s) of rapid apop-
totic cell disposal appears not to be detrimental to the host. No-
tably, CD14
 /  animals are healthy, inflammatory lesions asso-
ciated with persistent apoptotic cells are absent, autoantibody
production is similar to that of wild-type animals, and no au-
toimmune disease is detectable despite detailed histopathologi-
cal analyses of aged animals. Therefore, the results presented
here clearly demonstrate that apoptotic cells can persist without
consequent inflammation or autoimmune disease development
despite the susceptibility of the Balb/c strain to autoimmune
disease (Horai et al., 2000; Rudner et al., 2003). Indeed, our
findings raise the possibility that persistence under these cir-
cumstances may prolong the anti-inflammatory effects of ap-
optotic cells.
Materials and methods
Animals
Balb/c CD14
 /  mice were produced as described previously (Haziot et
al., 1996). For most studies, animals were used at 8–12 wk; for investiga-
tions of autoantibody production and autoimmune disease pathogenesis,
ages ranged from 10 to 20 mo. For some experiments, animals were in-
jected i.p. with 200  g dexamethasone (Organon) 24 h before sacrifice.
All animals were killed by cervical dislocation. All animal work was per-
formed under licence from the UK Home Office and with approval of the
Review Boards of the Universities of Nottingham and Edinburgh.
Qualitative and quantitative histology
Tissues were prepared either (1) by fixation in 4% PFA in 0.1 M of phos-
phate buffer, pH 7.3, followed by wax embedding or (2) by fixation in
1% PFA, 3% glutaraldehyde in 0.1 M of cacodylate buffer, pH 7.2, fol-
lowed by embedding in araldite resin. 6- m sections were cut from wax
blocks for standard hematoxylin and eosin staining, ISEL, or immunohis-
tochemistry. 1- m sections were cut from resin blocks for toluidine blue
staining and detailed light microscopic analyses. ISEL was performed us-
ing a FragEl kit (Calbiochem) as per the manufacturer’s instructions fol-
lowed by counterstaining with methyl green. Separate de-waxed sections
were immunostained with mAb F4/80 and visualized using a Vectastain
kit (Vector Laboratories). Quantitative light microscopic analyses were per-
formed according to standard morphometric procedures (Weibel, 1979)
using random systematic sampling of blocks, sections, and microscopic
fields from three CD14
 /  animals and matched CD14
 /  controls. In the
case of ISEL-labeled sections, numbers of labeled nuclei per unit area of
tissue were measured. For resin-embedded tissue (thymus and spleen), the
frequency of apoptotic cells/large apoptotic bodies per unit area was re-
corded. In addition, these events were subdivided according to whether
they were “free” or macrophage-associated (i.e., juxtaposed with a mac-
rophage or appearing within the cytoplasm of a macrophage). Given the
reticular nature of the macrophages identified by F4/80 staining, point-
counting (Weibel, 1979) was used to provide a measurement of the pro-
portional area of macrophage cytoplasm distributed throughout the tissues
analyzed (thymus and spleen). Hematoxylin- and eosin-stained sections of
kidney and secondary lymphoid tissues from aged animals were analyzed
for histopathological evidence of autoimmune disease.
Cell lines, cell isolation, and culture
The Burkitt lymphoma (BL) line Mutu I (Gregory et al., 1990) was cultured
in RPMI 1640 medium containing 2 mM L-glutamine supplemented with
10% Serum Supreme (BioWhittaker). COS-1 cells were cultured and trans-
fected with human CD14 cDNA as described previously (Devitt et al.,
1998). Monocytes were isolated from defibrinated blood (Flora and Greg-
ory, 1994) and cultured for 7 d in IMDM (Invitrogen) containing 10% au-
tologous serum on multi-well glass slides as described previously (Devitt etCD14 MEDIATES TETHERING OF APOPTOTIC CELLS • DEVITT ET AL. 1169
al., 1998). Thymocyte suspensions were prepared by mechanical disrup-
tion of thymi between frosted glass slides. Macrophages from bone mar-
row were isolated and cultured for 10 d on multi-well glass slides (Hend-
ley-Essex) in DME supplemented with 10% FCS, 2 mM L-glutamine, and
10% L cell–conditioned medium as described previously (Fadok et al.,
1992). Non-elicited peritoneal macrophages were lavaged from the peri-
toneal cavities of mice and adherent cells cultured on multi-well glass
slides in RPMI 1640 medium supplemented with 10% FCS, 2 mM L-gluta-
mine, and 10% L cell–conditioned medium for 1–2 d before use.
Apoptosis-induction and measurement in vitro
Apoptosis was induced by treatment (16–18 h) at 37 C of Mutu I cells with
1  g ml
 1 ionomycin (Sigma-Aldrich) or thymocytes with 1  M dexametha-
sone (Sigma-Aldrich). Apoptosis was assessed routinely by fluorescence mi-
croscopy of DAPI (Sigma-Aldrich)-stained cells (Devitt et al., 2003). Flow cy-
tometric analysis of apoptosis in thymocytes was undertaken using AxV
binding in combination with PI staining. Cells were washed into binding
buffer (10 mM Hepes, pH 7.4, 2.5 mM CaCl2, and 150 mM NaCl) and
stained with AxV-FITC (BioWhittaker). PI (20  g ml
 1; Sigma-Aldrich) was
added subsequently and samples were run directly on the Coulter XL flow
cytometer (Beckman Coulter). Percentages of cells that were (1) AxV
 PI
  (vi-
able), (2) AxV
 PI
  (apoptotic), or (3) AxV
 PI
  (necrotic) were enumerated.
Quantitative analyses of macrophage–apoptotic cell interactions
Human monocyte–derived, murine bone marrow–derived, or peritoneal
macrophages cultured on multi-well glass slides were coincubated with ap-
optotic cells (10
6 per well in RPMI containing 0.2% [wt/vol] BSA; Sigma-
Aldrich). In some experiments, the CD14 mAbs 61D3 or 63D3 (Devitt et
al., 1998) were included. After 30–60 min at 16–20 C (for tethering as-
says) or at 37 C (to include phagocytosis), unbound cells were removed
by extensive washing, and slides were fixed in methanol, stained with Jen-
ner/Giemsa (BDH), and mounted in DePeX (BDH) before examination by
light microscopy (Devitt et al., 2003). In certain tethering experiments,
COS-1 cells or COS-1/CD14 transfectants were used as “surrogate” mac-
rophages. For the i.p. interaction assay, a method modified from Taylor et
al. (2000) was used. In brief, freshly isolated autologous thymocytes were
fluorescently labeled with 1  M CMFDA (Molecular Probes) in PBS as per
the manufacturer’s instructions, and cultured at a density of 5   10
6/ml
for 16–18 h in RPMI containing10% FCS, 2 mM L-glutamine, and 1  M
dexamethasone (Sigma-Aldrich). Apoptotic thymocytes ( 90% apoptotic
as judged by DAPI-stained nuclear morphology) were washed thoroughly,
and 5   10
6 cells in 1 ml of sterile PBS were injected i.p. into CD14
 /  or
CD14
 /  mice. After 15-min interaction, i.p. cells were harvested and im-
munostained with F4-80-tri-color (Caltag Laboratories). Flow cytometry
was performed immediately to enumerate the proportion of F4/80-positive
cells (macrophages) that were associated with green (apoptotic) cells.
Phagocytosis of antibody-opsonized cells
BL cells were opsonized with excess CD19 mAb (mouse IgG1) at 4 C for
15 min, washed, and coincubated with BMDMs as described in the previ-
ous section. After 30 min at 37 C, unbound cells were removed and
phagocytosis was assessed by light microscopy of Jenner/Giemsa-stained
preparations. Duplicate wells of each sample were scored, with  200
macrophages per well being analyzed.
Production and binding of recombinant human CD14
Recombinant human CD14 was produced either as an Fc fusion protein or
his-tagged protein in 293 cells and purified using either protein G or
nickel affinity purification techniques. For staining, 200,000 cells were in-
cubated with 1  g of tagged CD14 for 30 min at 4 C. CD14-Fc was de-
tected by sequential staining steps with biotinylated goat anti–human IgG
(Sigma-Aldrich) and streptavidin-quantum red (Sigma-Aldrich). CD14-HIS
was similarly detected using murine anti-HIS mAb (Roche) and goat anti–
mouse-PE (Sigma-Aldrich).
Cytokine titers
Levels of TNF-  present in mouse sera collected postmortem were as-
sessed using an anti-mouse TNF-  ELISA kit (R&D Systems). The anti-
inflammatory effect of apoptotic cells was assessed as previously de-
scribed (Fadok et al., 1998a). In brief, murine macrophages were
treated with apoptotic thymocytes or apoptotic BL cells for 18 h in X-vivo
10 medium (BioWhittaker). For some wells, zymosan, opsonized with
human serum for 15 min at RT before washing, was added to a final
concentration of 100  g/ml. After the period of stimulation, culture su-
pernatants were assayed for TNF-  or TGF-  using anti-mouse TNF-  or
anti-mouse TGF-  ELISA kits (R&D Systems).
Autoantibody titers
ANA titers were assessed using previously described methods (Botto et
al., 1998; Cohen et al., 2002). In brief, sera collected immediately post-
mortem were diluted in PBS. Indirect immunofluorescence was performed
on acetone-fixed Hep-2 cell monolayers. The visualization reagent was
goat anti–mouse FITC (Sigma-Aldrich) slides being analyzed by standard
epifluorescence microscopy (model Zeiss Axioskop 2; Carl Zeiss MicroIm-
aging, Inc.). Dilutions of sera were tested from 1:80 to 1:2,560, and the
last dilution in the series to show reactivity was recorded for each animal.
A “negative” titer was given to those samples that showed no reactivity at
a 1:80 dilution.
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